HIV/AIDS Clinical Trials Network Laboratory Centers (UM1 Clinical Trial Required)
Open Posted
- Opportunity number
- RFA-AI-28-002
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.HL6 National Heart, Lung, and Blood Institute - Research Centers
- 93.DE1 Oral Diseases and Disorders Research -Research Projects
- 93.HDR Child Health and Human Development Extramural Research Projects
- 93.242 Mental Health Research Grants
- 93.KRC Diabetes, Digestive, Kidney Extramural Research - Research Centers
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- 93.AGR National Institute on Aging Research Projects
- 93.DA1 Drug Use and Addiction Research Programs - Research Projects
- 93.8RP National Institute of Allergy and Infectious Diseases- Research Projects
- 93.310 Trans-NIH Research Support
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Higher Education Inst. (Public)
- Special District Governments
- For Profit Organizations
- State Governments
- Public or Indian Housing Auth.
- 501(c)(3) Nonprofits
- Independent School Districts
- Higher Education Inst. (Private)
- Other
- Tribal Governments (Federally Recognized)
- Non-501(c)(3) Nonprofits
- City/Township Governments
- County Governments
- Tribal Organizations (Not Federally Recognized)
- Small Businesses
- Points of contact
Opportunity details come from Grants.gov. Updated .
About this opportunity
NIAID, part of the National Institutes of Health, is forecasting a cooperative agreement (UM1, clinical trial required) to fund up to four HIV/AIDS Clinical Trials Network Laboratory Centers under RFA-AI-28-002, with applications due February 9, 2027. The listing's due-date field reads March 9, 2027, which differs from the announcement text. The opportunity carries an estimated total commitment of $29 million across the four awards, a 7-year project period, and earliest start dates beginning March 9, 2027. Applicants must propose clinical trials.
Listed applicant types include public and private higher education institutions, state, county, city, and special district governments, federally recognized tribal governments, tribal organizations not federally recognized, 501(c)(3) and non-501(c)(3) nonprofits, for-profit organizations, small businesses, independent school districts, and public or Indian housing authorities. The government description adds eligible federal agencies, U.S. territories or possessions, faith-based or community-based organizations, regional organizations, and tribal governments not federally recognized. The source states no cost share requirement and no per-award ceiling or floor.
Each Laboratory Center will provide laboratory structure and technologies to one or more CTNs, conduct protocol-specified testing under regulatory standards, maintain sample integrity from collection through storage, implement data management systems, select and approve site-affiliated laboratories, and promote state-of-the-art assays. Applications must address laboratory center overview, scientific leadership and governance, laboratory science contributions, laboratory selection and quality assurance, specimen management, data management, operational oversight, communication and harmonization, and training and mentoring. All PD/PIs require eRA Commons accounts and ORCID registration. The source does not name an incumbent recipient.
Assistance Listing 93.855 (Allergy and Infectious Diseases Research) is the primary listing, and the opportunity is also assigned to 93.310 (Trans-NIH Research Support), 93.242 (Mental Health Research Grants), and others. Authority rests on Sections 301 and 405 of the Public Health Service Act, 42 CFR Part 52, and 2 CFR Part 200. Applicants direct scientific or financial questions to the relevant NIH institute.
Synopsis
The purpose of the notice of funding opportunity (NOFO) is to support HIV/AIDS Clinical Trials Network Laboratory Centers (LCs). The LCs will provide a framework for laboratory leadership, structure and activities that contribute to the HIV/AIDS Clinical Trials Networks research agendas and execute the laboratory component of Network trials, in compliance with applicable regulatory standards.
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
Files
| File | Type | Posted |
|---|---|---|
| PKG00294601.pdf | ||
| RFA-AI-28-002-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity